JP2020500903A5 - - Google Patents

Download PDF

Info

Publication number
JP2020500903A5
JP2020500903A5 JP2019530645A JP2019530645A JP2020500903A5 JP 2020500903 A5 JP2020500903 A5 JP 2020500903A5 JP 2019530645 A JP2019530645 A JP 2019530645A JP 2019530645 A JP2019530645 A JP 2019530645A JP 2020500903 A5 JP2020500903 A5 JP 2020500903A5
Authority
JP
Japan
Prior art keywords
cell
cell according
pharmaceutical composition
receptor
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019530645A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020500903A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/065488 external-priority patent/WO2018107134A1/en
Publication of JP2020500903A publication Critical patent/JP2020500903A/ja
Publication of JP2020500903A5 publication Critical patent/JP2020500903A5/ja
Priority to JP2023027231A priority Critical patent/JP2023078149A/ja
Pending legal-status Critical Current

Links

JP2019530645A 2016-12-09 2017-12-09 キメラクロロトキシン受容体 Pending JP2020500903A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023027231A JP2023078149A (ja) 2016-12-09 2023-02-24 キメラクロロトキシン受容体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662432404P 2016-12-09 2016-12-09
US62/432,404 2016-12-09
PCT/US2017/065488 WO2018107134A1 (en) 2016-12-09 2017-12-09 Chimeric chlorotoxin receptors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023027231A Division JP2023078149A (ja) 2016-12-09 2023-02-24 キメラクロロトキシン受容体

Publications (2)

Publication Number Publication Date
JP2020500903A JP2020500903A (ja) 2020-01-16
JP2020500903A5 true JP2020500903A5 (https=) 2021-01-28

Family

ID=62491409

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019530645A Pending JP2020500903A (ja) 2016-12-09 2017-12-09 キメラクロロトキシン受容体
JP2023027231A Pending JP2023078149A (ja) 2016-12-09 2023-02-24 キメラクロロトキシン受容体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023027231A Pending JP2023078149A (ja) 2016-12-09 2023-02-24 キメラクロロトキシン受容体

Country Status (9)

Country Link
US (2) US11421005B2 (https=)
EP (1) EP3551657B1 (https=)
JP (2) JP2020500903A (https=)
KR (2) KR102618373B1 (https=)
CN (1) CN110352197B (https=)
AU (1) AU2017371329B2 (https=)
CA (1) CA3044393A1 (https=)
IL (1) IL266950B2 (https=)
WO (1) WO2018107134A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4295914A3 (en) 2015-09-03 2024-04-10 The UAB Research Foundation Genetically-engineered drug resistant t cells and methods of using the same
KR102618373B1 (ko) 2016-12-09 2023-12-29 유에이비 리서치 파운데이션 키메라성 클로로톡신 수용체
US20230374085A1 (en) * 2020-03-11 2023-11-23 City Of Hope Dual-targeting chimeric antigen receptor modified t cells comprising il-13 and chlorotoxin for cancer treatment
CN115335407B (zh) * 2020-03-25 2024-08-27 北京艺妙神州医药科技有限公司 结合cd19的嵌合抗原受体及其用途
JP2024503507A (ja) * 2021-01-20 2024-01-25 インエイトバイオ，インコーポレイテッド 多価クロロトキシンキメラ抗原受容体

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5892019A (en) 1987-07-15 1999-04-06 The United States Of America, As Represented By The Department Of Health And Human Services Production of a single-gene-encoded immunoglobulin
PE20081140A1 (es) 2006-10-25 2008-09-22 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
CA2696303A1 (en) * 2007-08-07 2009-02-12 Transmolecular, Inc. Chlorotoxins as drug carriers
EP4032552B1 (en) * 2008-08-26 2023-10-04 City of Hope Method and compositions for enhanced anti-tumor effector functioning of t cells
EP2496244B8 (en) 2009-11-02 2017-11-22 Emory University Drug resistant immunotherapy for treatment of a cancer
JP5858932B2 (ja) * 2010-02-04 2016-02-10 モルフォテック， インコーポレイテッド クロロトキシンポリペプチドおよびコンジュゲートならびにその使用
EP2968601A1 (en) * 2013-03-10 2016-01-20 Baylor College Of Medicine Chemotherapy-resistant immune cells
WO2015031645A1 (en) 2013-08-28 2015-03-05 Washington University Monoclonal antibodies to human 14-3-3 epsilon and human 14-3-3 epsilon sv
GB201506423D0 (en) 2015-04-15 2015-05-27 Tc Biopharm Ltd Gamma delta T cells and uses thereof
CN115137752A (zh) 2015-08-25 2022-10-04 Uab研究基金会 用于干细胞移植的方法
EP4295914A3 (en) * 2015-09-03 2024-04-10 The UAB Research Foundation Genetically-engineered drug resistant t cells and methods of using the same
CA3001833A1 (en) * 2015-10-13 2017-04-20 City Of Hope Chimeric antigen receptors containing a chlorotoxin domain
KR102618373B1 (ko) 2016-12-09 2023-12-29 유에이비 리서치 파운데이션 키메라성 클로로톡신 수용체

Similar Documents

Publication Publication Date Title
JP2025032091A5 (https=)
RU2017105160A (ru) Лечение рака с помощью химерного антигенного рецептора к cd33
JP2021000103A5 (https=)
JP2020533958A5 (https=)
JP2019523301A5 (https=)
JP2020500903A5 (https=)
JP2018538339A5 (https=)
JP2017524367A5 (https=)
JP2017522879A5 (https=)
JP2022501043A5 (https=)
RU2017105161A (ru) Лечение рака с использованием химерного антигенного рецептора cll-1
RU2017105065A (ru) Лечение злокачественного новообразования с использованием гуманизированного химерного антигенного рецептора против всма
JP2021500881A5 (https=)
JP2018527014A5 (https=)
JP2019515661A5 (https=)
RU2017108903A (ru) Химерный антигенный рецептор (car) против cd123 для использования в лечении злокачественных опухолей
FI3844267T3 (fi) Menetelmät kimeeristä antigeenireseptoria ilmentävien solujen valmistamiseksi
JP2020513839A5 (https=)
IL266950B2 (en) ?? ? cells that express chimeric antigen receptor for use in immunotherapy
HRP20221348T1 (hr) Kimerni receptori i postupci njihove uporabe
JP2020517295A5 (https=)
JP2019516352A5 (https=)
JP2017522880A5 (https=)
JP2017527271A5 (https=)
JPWO2020061498A5 (https=)